DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Use Of Green Porphyrinsto Treat Neovasculature In The Eyes

Abstract

Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.

Inventors:
 [1];  [2];  [2];  [3];  [4]
  1. Vancouver, CA
  2. Boston, MA
  3. Arlington, MA
  4. Luebeck, DE
Issue Date:
Research Org.:
Massachusetts General Hospital
OSTI Identifier:
879252
Patent Number(s):
5798349
Application Number:
08/390591
Assignee:
The General Hospital Corporation (Boston, MA); Quadra Logic Technologies, Inc. (Vancouver, B.C., CA); Massachuesetts Eye & Ear Infirmary (Boston, MA)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
DOE Contract Number:  
FG02-91ER61228
Resource Type:
Patent
Country of Publication:
United States
Language:
English

Citation Formats

Levy, Julia, Miller, Joan W, Gradoudas, Evangelos S, Hasan, Tayyaba, and Schmidt-Erfurth, Ursula. Use Of Green Porphyrinsto Treat Neovasculature In The Eyes. United States: N. p., 1998. Web.
Levy, Julia, Miller, Joan W, Gradoudas, Evangelos S, Hasan, Tayyaba, & Schmidt-Erfurth, Ursula. Use Of Green Porphyrinsto Treat Neovasculature In The Eyes. United States.
Levy, Julia, Miller, Joan W, Gradoudas, Evangelos S, Hasan, Tayyaba, and Schmidt-Erfurth, Ursula. Tue . "Use Of Green Porphyrinsto Treat Neovasculature In The Eyes". United States. https://www.osti.gov/servlets/purl/879252.
@article{osti_879252,
title = {Use Of Green Porphyrinsto Treat Neovasculature In The Eyes},
author = {Levy, Julia and Miller, Joan W and Gradoudas, Evangelos S and Hasan, Tayyaba and Schmidt-Erfurth, Ursula},
abstractNote = {Photodynamic therapy of conditions of the eye characterized by unwanted neovasculature, such as age-related macular degeneration, is effective using green porphyrins as photoactive agents, preferably as liposomal compositions.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1998},
month = {8}
}

Works referenced in this record:

Photodynamic Therapy of Experimental Choroidal Melanoma Using Lipoprotein-delivered Benzoporphyrin
journal, January 1994


Efficient syntheses of new classes of regiochemically pure benzoporphyrin derivatives
journal, December 1993